Stock Analiz

Legend Biotech Corp (LEGN) financials: revenue, earnings and cash flow

Fiscal 2018–2025 + TTM · from SEC filings · data as of November 16, 2026

Summary

Legend Biotech’s revenue went from $49M in fiscal 2018 to $1.0B in fiscal 2025, growth of about 54.4% a year.

Net income in fiscal 2025 was -$297M, a net margin of -28.8%; the best year in this period was 2018 with -$3M.

Over the twelve months to September 30, 2026, revenue was $1.4B and net income -$200000.

Free cash flow was -$129M in fiscal 2025 and positive in 1 of the 8 years shown.

Revenue, profit and cash flow by year

Revenue
2018: $49M20182019: $60M20192020: $75M20202021: $69M20212022: $117M20222023: $285M20232024: $627M20242025: $1.0B2025$1.0B
Net income
2018: -$3M20182019: -$102M20192020: -$266M20202021: -$404M20212022: -$446M20222023: -$518M20232024: -$177M20242025: -$297M2025-$297M
Free cash flow
2018: $287M20182019: -$110M20192020: -$249M20202021: -$241M20212022: -$222M20222023: -$413M20232024: -$158M20242025: -$129M2025-$129M
EPS (diluted)
2018: $-0.0120182019: $-0.5220192020: $-1.3720202021: $-2.0820212022: $-2.2920222023: $-2.6620232024: $-0.9120242025: $-1.532025$-1.53

Income statement

Fiscal yearTTM20252024202320222021202020192018
Revenue$1.4B$1.0B$627M$285M$117M$69M$75M$60M$49M
Gross profit—$632M$411M$141M$52M$69M$75M——
Operating income—-$136M-$310M-$528M-$446M-$407M-$308M——
Net income-$200000-$297M-$177M-$518M-$446M-$404M-$266M-$102M-$3M
EPS (diluted)$-0.00$-1.53$-0.91$-2.66$-2.29$-2.08$-1.37$-0.52$-0.01
R&D—————————
Revenue growth—+64.0%+120.0%+143.7%+70.0%−8.2%+25.0%+22.1%—

Cash flow

Fiscal yearTTM20252024202320222021202020192018
Operating cash flow-$154M-$100M-$144M-$393M-$201M-$198M-$223M-$83M$308M
Capital spending-$33M-$29M-$14M-$20M-$21M-$42M-$26M-$27M-$21M
Free cash flow-$187M-$129M-$158M-$413M-$222M-$241M-$249M-$110M$287M
Dividends paid—$0$0$0$0$0$0$0$0
Buybacks—————————
Stock-based pay—————————

Balance sheet

Fiscal yearTTM20252024202320222021202020192018
Cash—$902M$287M$1.3B$786M$689M$456M$83M$210M
Debt—$319M$301M$281M$261M$120M———
Equity—$1.0B$1.0B$1.3B$744M$766M$598M-$123M$253M
Total assets—$1.7B$1.7B$1.8B$1.3B$1.1B$722M$288M—
Shares (diluted)192M194M194M194M194M194M194M194M194M

Margins and returns

Fiscal yearTTM20252024202320222021202020192018
Gross margin—61.4%65.5%49.4%44.1%100.0%100.0%——
Operating margin—-13.3%-49.3%-185.2%-380.9%-591.6%-411.1%——
Net margin-0.0%-28.8%-28.2%-181.8%-381.5%-586.4%-355.2%-169.4%-5.7%
FCF margin-13.8%-12.5%-25.2%-145.0%-189.9%-349.7%-332.4%-183.1%583.6%
ROIC—-8.2%-18.2%-34.3%-35.0%-45.5%-44.6%——
ROE—-29.6%-17.0%-41.4%-60.0%-52.7%-44.6%82.7%-1.1%

Frequently asked questions

What is Legend Biotech’s annual revenue?

$1.0B in fiscal 2025 and $1.4B over the twelve months to September 30, 2026.

How much profit does Legend Biotech make?

Net income was -$297M in fiscal 2025 (net margin -28.8%).

Is Legend Biotech’s revenue growing?

Yes: revenue rose 64.0% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.